Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan W Day

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Biochemical Pharmacology|February 11, 2021
MerTK activity is not necessary for the proliferation of glioblastoma stem cellsMonira Hoque, Siu Wai Wong, Ariadna Recasens, et al.
Neuro-Oncology Practice|April 8, 2020
Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobankingCraig Gedye, Mythily Sachchithananthan, Robyn Leonard, et al.
Anatomy & Cell Biology|March 26, 2015
Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell linesMaryam Rahman, Karina Reyner, Loic Deleyrolle, et al.
The Journal of Biological Chemistry|November 23, 2013
A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesisHazem J Abuhusain, Azadeh Matin, Qiao Qiao, et al.
Journal for Immunotherapy of Cancer|August 7, 2024
EphA3 CAR T cells are effective against glioblastoma in preclinical modelsPaulo Martins, Rochelle C J D'Souza, Niclas Skarne, et al.
Science Advances|January 30, 2026
Monitoring glioblastoma extracellular vesicle evolution using a nanodiagnostic platform to detect glioma stem cells driving recurrent diseaseZhen Zhang, Richard J Lobb, Paul Tooney, et al.
Molecular Oncology|July 15, 2014
Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cellsYi Chieh Lim, Tara L Roberts, Bryan W Day, et al.
The Journal of Cell Biology|December 7, 2011
Eph receptor function is modulated by heterooligomerization of A and B type Eph receptorsPeter W Janes, Bettina Griesshaber, Lakmali Atapattu, et al.
Cancers|February 10, 2019
Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in GlioblastomaSeçkin Akgül, Ann-Marie Patch, Rochelle C J D'Souza, et al.
Molecular Imaging|July 29, 2015
EphA2 as a Diagnostic Imaging Target in Glioblastoma: A Positron Emission Tomography/Magnetic Resonance Imaging StudySimon Puttick, Brett W Stringer, Bryan W Day, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Biochemical Pharmacology|February 11, 2021
MerTK activity is not necessary for the proliferation of glioblastoma stem cellsMonira Hoque, Siu Wai Wong, Ariadna Recasens, et al.
Neuro-Oncology Practice|April 8, 2020
Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobankingCraig Gedye, Mythily Sachchithananthan, Robyn Leonard, et al.
Anatomy & Cell Biology|March 26, 2015
Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell linesMaryam Rahman, Karina Reyner, Loic Deleyrolle, et al.
The Journal of Biological Chemistry|November 23, 2013
A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesisHazem J Abuhusain, Azadeh Matin, Qiao Qiao, et al.
Journal for Immunotherapy of Cancer|August 7, 2024
EphA3 CAR T cells are effective against glioblastoma in preclinical modelsPaulo Martins, Rochelle C J D'Souza, Niclas Skarne, et al.
Science Advances|January 30, 2026
Monitoring glioblastoma extracellular vesicle evolution using a nanodiagnostic platform to detect glioma stem cells driving recurrent diseaseZhen Zhang, Richard J Lobb, Paul Tooney, et al.
Molecular Oncology|July 15, 2014
Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cellsYi Chieh Lim, Tara L Roberts, Bryan W Day, et al.
The Journal of Cell Biology|December 7, 2011
Eph receptor function is modulated by heterooligomerization of A and B type Eph receptorsPeter W Janes, Bettina Griesshaber, Lakmali Atapattu, et al.
Cancers|February 10, 2019
Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in GlioblastomaSeçkin Akgül, Ann-Marie Patch, Rochelle C J D'Souza, et al.
Molecular Imaging|July 29, 2015
EphA2 as a Diagnostic Imaging Target in Glioblastoma: A Positron Emission Tomography/Magnetic Resonance Imaging StudySimon Puttick, Brett W Stringer, Bryan W Day, et al.
Pageof 8